1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
(
- Contribution to journal › Article
- 2012
-
Mark
Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenografts
(
- Contribution to journal › Article
-
Mark
Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.
(
- Contribution to journal › Article
- 2009
-
Mark
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study.
(
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.
(
- Contribution to journal › Article
-
Mark
The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay.
(
- Contribution to journal › Article
- 2007
-
Mark
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer
(
- Contribution to journal › Article
- 2005
-
Mark
In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line.
(
- Contribution to journal › Article